Entering text into the input field will update the search result below

CDTV.net Stock Market News and Dividend Report for Mon Jan 3, 2011

Jan. 03, 2011 7:47 PM ETBMY, MAS, DRI
John Hanna profile picture
John Hanna's Blog
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
The Board of Directors of Bristol-Myers Squibb Company (NYSE: BMY) declared a 3.1 percent increase in the company’s quarterly dividend, beginning in the first quarter of 2011. The dividend increase will result in a quarterly dividend of thirty-three cents ($0.33) per share. The next quarterly dividend will be payable on February 1, 2011, to stockholders of record at the close of business on January 7, 2011.
Bristol-Myers Squibb is a global biopharmaceutical 
Masco Corporation (NYSE: MAS) Board of Directors declared a quarterly dividend of $.075 per common share, payable on February 7, 2011, to shareholders of record on January 7, 2011.
Masco Corporation is one of the world's leading manufacturers of home improvement and building products,
Darden Restaurants, Inc. (NYSE: DRI) Board of Directors declared a quarterly dividend of 32 cents per share on the Company's outstanding common stock.  The dividend is payable on February 1, 2011 to shareholders of record at the close of business on January 10, 2011.
Darden Restaurants, Inc., (NYSE: DRI) is the world's largest company-owned and operated full-service restaurant company 
For more information, visit cdtv.net
Disclosure: No positions
Municipal Bond Investing on January 19, 2011 Online Audio Webinar / Web Conference. For more information, visit www.cdtv.net/users/content/municipal-bon...

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.